Saturday, October 31, 2026

Kodak Stock Was Up By 59.96% On Monday

ViaNews Editorial Team

December 8, 2020

Kodak Stock Was Up By 59.96% On Monday
The New York Stock Exchange ended the session with Kodak jumping 59.96% to $12.05 on Monday while the New York Stock Exchange slid 0.43% to $14,355.00. Kodak today's close was $12.05, 397.93% under its 52-week high of $60.00.

Kodak's Revenue

Year-on-year quarterly revenue growth declined by 20%, now sitting on 1.06B for the twelve trailing months.

Kodak's Stock Top and Bottom Yearly Value

Kodak's stock is valued at $12.05 at 21:01 EST, way under its 52-week high of $60.00 and way higher than its 52-week low of $1.50.

Kodak's Moving Average

Kodak's worth is way higher than its 50-day moving average of $7.40 and way above its 200-day moving average of $6.75.

Previous days news about Kodak

Watchdog finds no wrongdoing in Kodak deal. According to The Wall Street Journal on Sun Dec 6, "A government watchdog agency found no wrongdoing in the process that created a now-halted U.S. loan to Eastman Kodak Co. to produce drug ingredients for the Covid-19 response, according to a copy of the assessment reviewed by The Wall Street Journal." Kodak shares surge 60% premarket on report of loan probe outcome. According to Bloomberg Quint on Mon Dec 7, "Eastman Kodak Co. surged about 60% in premarket trading after a press report that a probe found no wrongdoing regarding a government loan to the photography giant turned pharmaceutical manufacturer.The inspector general of the agency that brokered the deal, the U.S." Kodak stock surges 98% after federal watchdog finds no problems with halted $765 million government loan. According to Business Insider on Mon Dec 7, "Kodak shares soared as much as 98% in pre-market trading on Monday after a government watchdog found no problems with the process that created a $765 million federal loan to finance the camera company's pivot toward making COVID-19 drug ingredients earlier this year."
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com